Activated T cell-derived exosomes for targeted delivery of AXL-siRNA loaded paclitaxel-poly-L-lysine prodrug to overcome drug resistance in triple-negative breast cancer-Reference-Cited by-同舟云学术

Activated T cell-derived exosomes for targeted delivery of AXL-siRNA loaded paclitaxel-poly-L-lysine prodrug to overcome drug resistance in triple-negative breast cancer

Published:2023-07 Issue: Volume:468 Page:143454
ISSN:1385-8947
Container-title:Chemical Engineering Journal
language:en
Short-container-title:Chemical Engineering Journal

Author:

Chen Chuanrong,Shen Ming,Wan Xiaofeng,Sheng Lili,He Yang,Xu Menglin,Yuan Meng^ORCID,Ji Zhaoning,Zhang Jiali^ORCID

Publisher

Elsevier BV

Subject

Industrial and Manufacturing Engineering,General Chemical Engineering,Environmental Chemistry,General Chemistry

Reference48 articles.

1. A. Garrido-Castro, N. Lin, K. Polyak, Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment, Cancer Discov. 9(2) (2019) 176-198. doi: 10.1158/2159-8290.Cd-18-1177.

2. Recent advances in therapeutic strategies for triple-negative breast cancer;Li;J. Hematol. Oncol.,2022

3. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs;Bianchini;Nat. Rev. Clin. Oncol.,2022

4. Codelivery of anti-PD-1 antibody and paclitaxel with matrix metalloproteinase and pH dual-sensitive micelles for enhanced tumor chemoimmunotherapy;Su;Small,2020

5. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial;Schmid;Lancet Oncol.,2020

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy;Bioactive Materials;2024-11

2. Strategic chemical synthesis and application of nanocarriers responsive to the tumor microenvironment;Nano Today;2024-10

3. Dendritic polylysine co-delivery of paclitaxel and siAXL enhances the sensitivity of triple-negative breast cancer chemotherapy;Frontiers in Bioengineering and Biotechnology;2024-08-01

4. Celecoxib Augments Paclitaxel-Induced Immunogenic Cell Death in Triple-Negative Breast Cancer;ACS Nano;2024-06-03

5. Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade;Advanced Drug Delivery Reviews;2024-06